Assertio Newsroom

Maxim Group Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3

Futu NewsNov 13 21:33

A. G. P. Maintains Assertio(ASRT.US) With Buy Rating, Cuts Target Price to $2.15

Futu NewsNov 13 05:31

Lake Street Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3

Futu NewsNov 12 22:31

Assertio Therapeutics (ASRT) Receives a Buy From Lake Street

TipRanksNov 12 21:57

Lake Street Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3

Futu NewsAug 19 21:33

Assertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic Growth

TipRanksAug 19 21:06

Assertio Holdings Price Target Announced at $3.00/Share by Maxim Group

Dow JonesJul 27 00:44

Assertio Holdings Analyst Ratings

BenzingaJul 27 00:34

Maxim Group Initiates Assertio(ASRT.US) With Buy Rating, Announces Target Price $3

Futu NewsJul 26 20:34

H.C. Wainwright Starts Assertio at Buy, Calls Stock Underrated, Overlooked

Seeking AlphaJul 4 03:47

Assertio Holdings Analyst Ratings

BenzingaJul 3 18:17

Analysts Are Bullish on These Healthcare Stocks: Assertio Therapeutics (ASRT), SurModics (SRDX)

TipRanksMay 29 21:00

Assertio Holdings Analyst Ratings

BenzingaMay 29 01:05

Assertio Holdings Inc: Alliance Global Partners Launch Report with Buy Rating and $2.75 Target Share Price

Zhitong FinanceMay 28 19:05

Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Longboard Pharmaceuticals (LBPH) and Travere Therapeutics (TVTX)

TipRanksMay 7 21:11

Assertio Holdings Analyst Ratings

BenzingaMar 13 00:15

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Henry Schein (HSIC) and Assertio Therapeutics (ASRT)

TipRanksNov 10, 2023 17:32

BWS Financial Maintains Buy on Assertio Holdings, Lowers Price Target to $4

BenzingaNov 4, 2023 05:32

Assertio Holdings Analyst Ratings

BenzingaNov 4, 2023 05:30

Assertio Therapeutics Earns Buy Rating Amid Strategic Acquisitions and Anticipated Rolvedon Revenue Growth

TipRanksNov 3, 2023 22:35